Catalog number,old,MW,Plate Location,Plate number,96 plate name,96 well,384 plate ID,UCSC CSC plate ID,Well,Plate description,Concentration,Compound description,Solvent,Plate part number,MoleculeID
SL-115,C16 Ceramide,537.9,1-A02,1,Plate 1,A02,EnzoICCB1,SP0127,A03,ICCB Known Bioactives Library,1,Bioactive lipids:  Activates PKC zeta,DMSO,2840,C16 Ceramide  - Bioactive lipids - Activates PKC zeta
L-120,C-PAF,538.7,2-A02,2,Plate 2,A02,EnzoICCB1,SP0127,A04,ICCB Known Bioactives Library,1,Bioactive lipids:  PAF receptor agonist,DMSO,2840,C-PAF  - Bioactive lipids - PAF receptor agonist
SL-145,C8 Ceramine,411.7,1-A03,1,Plate 1,A03,EnzoICCB1,SP0127,A05,ICCB Known Bioactives Library,1,Bioactive lipids:  Ceramide analog. Apoptosis inducer,DMSO,2840,C8 Ceramine - Bioactive lipids - Ceramide analog. Apoptosis inducer
PG-047,D12-Prostaglandin J2,334.4,2-A03,2,Plate 2,A03,EnzoICCB1,SP0127,A06,ICCB Known Bioactives Library,1,Bioactive lipids:  Bioactive prostaglandin,DMSO,2840,Delta 12-Prostaglandin J2  - Bioactive lipids - Bioactive prostaglandin
FA-021,(R)-(+)-Methandamide,361.6,1-A04,1,Plate 1,A04,EnzoICCB1,SP0127,A07,ICCB Known Bioactives Library,1,CNS receptor ligands:  Cannabinoid CB1 receptor agonist,DMSO,2840,(R)-Methanandamide  - CNS receptor ligands - Cannabinoid CB1 receptor agonist
FA-009,Dihomo-gamma-linolenic acid,306.5,2-A04,2,Plate 2,A04,EnzoICCB1,SP0127,A08,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid ,DMSO,2840,Dihomo-gamma-linolenic acid - Bioactive lipids - Polyunsaturated fatty acid 
DM-200,1?;25-Dihydroxyvitamin D3,416.6,1-A05,1,Plate 1,A05,EnzoICCB1,SP0127,A09,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  Vitamin D receptor agonist,DMSO,2840,1;25-Dihydroxyvitamin D3  - Nuclear receptor ligands - Vitamin D receptor agonist
SL-125,Dihydrosphingosine,301.5,2-A05,2,Plate 2,A05,EnzoICCB1,SP0127,A10,ICCB Known Bioactives Library,1,Bioactive lipids:  Apoptosis inducer,DMSO,2840,Dihydrosphingosine  - Bioactive lipids - Apoptosis inducer
DG-100,1;2-Didecanoyl-glycerol (10:0),400.6,1-A06,1,Plate 1,A06,EnzoICCB1,SP0127,A11,ICCB Known Bioactives Library,1,Bioactive lipids:  Activates PKC,DMSO,2840,1;2-Didecanoyl-glycerol (10:0)  - Bioactive lipids - Activates PKC
GR-207,Diidolylmethane,246.3,2-A06,2,Plate 2,A06,EnzoICCB1,SP0127,A12,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  AHR agonist,DMSO,2840,Diindolylmethane - Nuclear receptor ligands - AHR agonist
DG-112,1;2-Dioctanoyl-SN-glycerol,344.5,1-A07,1,Plate 1,A07,EnzoICCB1,SP0127,A13,ICCB Known Bioactives Library,1,Bioactive lipids:  Activates PKC,DMSO,2840,1;2-Dioctanoyl-sn-glycerol - Bioactive lipids - Activates PKC
SL-205,DL-Dihydrosphingosine,301.5,2-A07,2,Plate 2,A07,EnzoICCB1,SP0127,A14,ICCB Known Bioactives Library,1,Lipid biosynthesis:  Sphingosine kinase inhibitor,DMSO,2840,DL-Dihydrosphingosine - Lipid biosynthesis - Sphingosine kinase inhibitor
DG-115,1;2-Dioleoyl-glycerol (18:1),621.0,1-A08,1,Plate 1,A08,EnzoICCB1,SP0127,A15,ICCB Known Bioactives Library,1,Bioactive lipids:  Activates PKC,DMSO,2840,1;2-Dioleoyl-glycerol (18:1)  - Bioactive lipids - Activates PKC
SL-210,DL-PDMP,390.6,2-A08,2,Plate 2,A08,EnzoICCB1,SP0127,A16,ICCB Known Bioactives Library,1,Lipid biosynthesis:  Glucosylceramide synthase inhibitor,DMSO,2840,DL-PDMP  - Lipid biosynthesis - Glucosylceramide synthase inhibitor
EE-11,(±)11(12)-Epoxyeicosatrienoic acid,320.5,1-A09,1,Plate 1,A09,EnzoICCB1,SP0127,A17,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive arachidonic acid metabolite,DMSO,2840,11;12-Epoxyeicosatrienoic acid  - Bioactive lipids - Bioactive arachidonic acid metabolite
SL-215,DL-PPMP,474.7,2-A09,2,Plate 2,A09,EnzoICCB1,SP0127,A18,ICCB Known Bioactives Library,1,Lipid biosynthesis:  Glucosylceramide synthase inhibitor,DMSO,2840,DL-PPMP  - Lipid biosynthesis - Glucosylceramide synthase inhibitor
H-112,12(R)-HETE,320.5,1-A10,1,Plate 1,A10,EnzoICCB1,SP0127,A19,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive arachidonic acid metabolite,DMSO,2840,12(R)-HETE   - Bioactive lipids - Bioactive arachidonic acid metabolite
FA-002,Docosahexaenoic acid(22:6 n-3),328.5,2-A10,2,Plate 2,A10,EnzoICCB1,SP0127,A20,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid ,DMSO,2840,Docosahexaenoic acid (22:6 n-3)  - Bioactive lipids - Polyunsaturated fatty acid 
H-012,12(S)-HETE,320.5,1-A11,1,Plate 1,A11,EnzoICCB1,SP0127,A21,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive arachidonic acid metabolite,DMSO,2840,12(S)-HETE  - Bioactive lipids - Bioactive arachidonic acid metabolite
FA-012,Docosapentaenoic acid,330.5,2-A11,2,Plate 2,A11,EnzoICCB1,SP0127,A22,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid ,DMSO,2840,Docosapentaenoic acid   - Bioactive lipids - Polyunsaturated fatty acid 
AC-104,Bepridil·HCl,403.0,3-A02,3,Plate 3,A02,EnzoICCB1,SP0127,B03,ICCB Known Bioactives Library,12.4069478908189,Ion channel ligands:  Calcium channels,DMSO,2840,Bepridil - Ion channel ligands - Calcium channels
GR-313,Lycorine,287.3,4-A02,4,Plate 4,A02,EnzoICCB1,SP0127,B04,ICCB Known Bioactives Library,17.4027750465089,Inhibitors:  inhibits TNFalpha production,DMSO,2840,Lycorine - Inhibitors - inhibits TNFalpha production
CA-415,Cyclopiazonic acid,336.4,3-A03,3,Plate 3,A03,EnzoICCB1,SP0127,B05,ICCB Known Bioactives Library,14.8639473174142,Ion channel ligands:  Intracellular calcium,DMSO,2840,Cyclopiazonic acid - Ion channel ligands - Intracellular calcium
GR-316,10-hydroxycamptothecin,364.4,4-A03,4,Plate 4,A03,EnzoICCB1,SP0127,B06,ICCB Known Bioactives Library,13.723015747984,Inhibitors:  topoisomerase 1 inhibitor,DMSO,2840,10-Hydroxycamptothecin - Inhibitors - topoisomerase 1 inhibitor
AC-100,Dantrolene,314.3,3-A04,3,Plate 3,A04,EnzoICCB1,SP0127,B07,ICCB Known Bioactives Library,15.9107470732181,Ion channel ligands:  Intracellular calcium,DMSO,2840,Dantrolene - Ion channel ligands - Intracellular calcium
GR-308,beta-lapachone,242.3,4-A04,4,Plate 4,A04,EnzoICCB1,SP0127,B08,ICCB Known Bioactives Library,20.6381395295082,Inhibitors:  topoisomerase 1 inhibitor,DMSO,2840,?-Lapachone - Inhibitors - topoisomerase 1 inhibitor
KC-115,Diazoxide,230.7,3-A05,3,Plate 3,A05,EnzoICCB1,SP0127,B09,ICCB Known Bioactives Library,21.6758933719453,Ion channel ligands:  Potassium channels,DMSO,2840,Diazoxide - Ion channel ligands - Potassium channels
T-113,Parthenolide,248.3,4-A05,4,Plate 4,A05,EnzoICCB1,SP0127,B10,ICCB Known Bioactives Library,20.1355119957313,Inhibitors:  IkappaB kinase inhibitor,DMSO,2840,Parthenolide - Inhibitors - IkappaB kinase inhibitor
CA-204,Dichlorobenzamil·HCl,425.1,3-A06,3,Plate 3,A06,EnzoICCB1,SP0127,B11,ICCB Known Bioactives Library,11.7619106988692,Ion channel ligands:  Calcium channels,DMSO,2840,Dichlorobenzamil - Ion channel ligands - Calcium channels
PI-102,MG-132,475.6,4-A06,4,Plate 4,A06,EnzoICCB1,SP0127,B12,ICCB Known Bioactives Library,10.5125764054053,Protease inhibitors:  Proteasome inhibitor,DMSO,2840,MG-132 - Protease inhibitors - Proteasome inhibitor
CA-205,Diltiazem·HCl,451.0,3-A07,3,Plate 3,A07,EnzoICCB1,SP0127,B13,ICCB Known Bioactives Library,11.0869907467975,Ion channel ligands:  Calcium channels,DMSO,2840,Diltiazem - Ion channel ligands - Calcium channels
EI-352,QNZ,356.4,4-A07,4,Plate 4,A07,EnzoICCB1,SP0127,B14,ICCB Known Bioactives Library,14.0283777247318,Inhibitors:  NFkappaB inhibitor,DMSO,2840,QNZ
KC-158,E-4031,401.5,3-A08,3,Plate 3,A08,EnzoICCB1,SP0127,B15,ICCB Known Bioactives Library,12.4526177893117,Ion channel ligands:  Potassium channels,DMSO,2840,E-4031 - Ion channel ligands - Potassium channels
GR-211,bezafibrate,361.8,4-A08,4,Plate 4,A08,EnzoICCB1,SP0127,B16,ICCB Known Bioactives Library,13.8190642282467,Nuclear receptor ligands:  PPAR alpha agonist,DMSO,2840,Bezafibrate - Nuclear receptor ligands - PPAR alpha agonist
CM-102,Fipronil,437.1,3-A09,3,Plate 3,A09,EnzoICCB1,SP0127,B17,ICCB Known Bioactives Library,11.4377739346857,Ion channel ligands:  Misc. channels,DMSO,2840,Fipronil - Ion channel ligands - Misc. channels
IM-100,Cycloheximide-N-ethylethanoate,367.4,4-A09,4,Plate 4,A09,EnzoICCB1,SP0127,B18,ICCB Known Bioactives Library,13.6077860485901,Inhibitors:  FKBP12 inhibitor,DMSO,2840,Cycloheximide-N-ethylethanoate - Inhibitors - FKBP12 inhibitor
AC-130,Flecainide acetate,473.4,3-A10,3,Plate 3,A10,EnzoICCB1,SP0127,B19,ICCB Known Bioactives Library,10.5621894320225,Ion channel ligands:  Sodium channels,DMSO,2840,Flecainide - Ion channel ligands - Sodium channels
A-165,Ascomycin (FK-520),792.0,4-A10,4,Plate 4,A10,EnzoICCB1,SP0127,B20,ICCB Known Bioactives Library,6.31307153025697,Inhibitors:  binds to FKBP inhibits calcineurin,DMSO,2840,Ascomycin (FK-520) - Inhibitors - binds to FKBP inhibits calcineurin
AC-123,Flufenamic acid,281.2,3-A11,3,Plate 3,A11,EnzoICCB1,SP0127,B21,ICCB Known Bioactives Library,17.7790483871025,Ion channel ligands:  Potassium channels,DMSO,2840,Flufenamic acid - Ion channel ligands - Potassium channels
FR-100,U-74389G,610.8,4-A11,4,Plate 4,A11,EnzoICCB1,SP0127,B22,ICCB Known Bioactives Library,8.18555808889483,Inhibitors:  superoxide/free-radical inhibitor,DMSO,2840,U-74389G - Inhibitors - superoxide/free-radical inhibitor
HP-012,12(S)-HPETE,336.5,1-B02,1,Plate 1,B02,EnzoICCB1,SP0127,C03,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Fatty acid hydroperoxide,DMSO,2840,12(S)-HPETE  - Bioactive lipids - Fatty acid hydroperoxide
FA-010,Docosatrienoic acid (22:3 n-3),334.5,2-B02,2,Plate 2,B02,EnzoICCB1,SP0127,C04,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid ,DMSO,2840,Docosatrienoic acid (22:3 n-3) - Bioactive lipids - Polyunsaturated fatty acid 
G-234,12-Methoxydodecanoic acid,230.3,1-B03,1,Plate 1,B03,EnzoICCB1,SP0127,C05,ICCB Known Bioactives Library,1,Bioactive lipids:  Myristic acid analog,DMSO,2840,12-Methoxydodecanoic acid - Bioactive lipids - Myristic acid analog
FA-024,Eicosa-5;8-dienoic acid (20:2 n-12),308.5,2-B03,2,Plate 2,B03,EnzoICCB1,SP0127,C06,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid ,DMSO,2840,Eicosa-5;8-dienoic acid (20:2 n-12) - Bioactive lipids - Polyunsaturated fatty acid 
HO-013,13(S)-HODE,296.4,1-B04,1,Plate 1,B04,EnzoICCB1,SP0127,C07,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive linoleic acid metabolite,DMSO,2840,13(S)-HODE  - Bioactive lipids - Bioactive linoleic acid metabolite
FA-007,Eicosadienoic acid (20:2 n-6),308.5,2-B04,2,Plate 2,B04,EnzoICCB1,SP0127,C08,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid ,DMSO,2840,Eicosadienoic acid (20:2 n-6)  - Bioactive lipids - Polyunsaturated fatty acid 
HP-013,13(S)-HPODE,312.4,1-B05,1,Plate 1,B05,EnzoICCB1,SP0127,C09,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Fatty acid hydroperoxide,DMSO,2840,13(S)-HPODE  - Bioactive lipids - Fatty acid hydroperoxide
FA-001,Eicosapentaenoic acid (20:5 n-3),302.5,2-B05,2,Plate 2,B05,EnzoICCB1,SP0127,C10,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid ,DMSO,2840,Eicosapentaenoic acid (20:5 n-3)  - Bioactive lipids - Polyunsaturated fatty acid 
PG-048,13;14-Dihydro-PGE1,356.5,1-B06,1,Plate 1,B06,EnzoICCB1,SP0127,C11,ICCB Known Bioactives Library,1,Bioactive lipids:  Bioactive prostaglandin,DMSO,2840,13;14-Dihydro-prostaglandin E1  - Bioactive lipids - Bioactive prostaglandin
FA-008,Eicosatrienoic acid (20:3 n-3),306.5,2-B06,2,Plate 2,B06,EnzoICCB1,SP0127,C12,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid ,DMSO,2840,Eicosatrienoic acid (20:3 n-3)  - Bioactive lipids - Polyunsaturated fatty acid 
GR-102,13-cis retinoic acid,300.4,1-B07,1,Plate 1,B07,EnzoICCB1,SP0127,C13,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  Retinoid receptor ligand,DMSO,2840,13-cis Retinoic acid - Nuclear receptor ligands - Retinoid receptor ligand
L-110,Enantio-PAF C16,523.7,2-B07,2,Plate 2,B07,EnzoICCB1,SP0127,C14,ICCB Known Bioactives Library,1,Bioactive lipids:  Negative control for PAF,DMSO,2840,Enantio-PAF C16  - Bioactive lipids - Negative control for PAF
KO-013,13-Keto-octadeca-9Z;11E-dienoic acid,294.4,1-B08,1,Plate 1,B08,EnzoICCB1,SP0127,C15,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive linoleic acid metabolite,DMSO,2840,13-Ketooctadecadienoic acid - Bioactive lipids - Bioactive linoleic acid metabolite
G-222,Farnesylthioacetic acid,296.5,2-B08,2,Plate 2,B08,EnzoICCB1,SP0127,C16,ICCB Known Bioactives Library,1,Bioactive lipids:  Carboxymethylation inhibitor,DMSO,2840,Farnesylthioacetic acid  - Bioactive lipids - Carboxymethylation inhibitor
EE-14,(±)14;15-Epoxyeicosa-5Z;8Z;11Z-trienoic acid,320.5,1-B09,1,Plate 1,B09,EnzoICCB1,SP0127,C17,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive arachidonic acid metabolite,DMSO,2840,14;15-Epoxyeicosatrienoic acid  - Bioactive lipids - Bioactive arachidonic acid metabolite
RA-105,Fluprostenol,458.5,2-B09,2,Plate 2,B09,EnzoICCB1,SP0127,C18,ICCB Known Bioactives Library,1,Bioactive lipids:  Prostaglandin FP receptor agonist,DMSO,2840,Fluprostenol - Bioactive lipids - Prostaglandin FP receptor agonist
H-015,15(S)-HETE,320.5,1-B10,1,Plate 1,B10,EnzoICCB1,SP0127,C19,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive arachidonic acid metabolite,DMSO,2840,15(S)-HETE  - Bioactive lipids - Bioactive arachidonic acid metabolite
FA-006,Gamma-linolenic acid (18:3 n-6),278.4,2-B10,2,Plate 2,B10,EnzoICCB1,SP0127,C20,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid ,DMSO,2840,?-Linolenic acid (18:3 n-6)  - Bioactive lipids - Polyunsaturated fatty acid 
HP-015,15(S)-HPETE,336.5,1-B11,1,Plate 1,B11,EnzoICCB1,SP0127,C21,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Fatty acid hydroperoxide,DMSO,2840,15(S)-HPETE  - Bioactive lipids - Fatty acid hydroperoxide
LE-009,Leukotoxin A (9;10-EODE),296.4,2-B11,2,Plate 2,B11,EnzoICCB1,SP0127,C22,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive linoleic acid metabolite,DMSO,2840,Leukotoxin A (9;10-EODE)  - Bioactive lipids - Bioactive linoleic acid metabolite
CA-225,Flunarizine·2HCl,477.4,3-B02,3,Plate 3,B02,EnzoICCB1,SP0127,D03,ICCB Known Bioactives Library,10.4730246304593,Ion channel ligands:  Calcium channels,DMSO,2840,Flunarizine - Ion channel ligands - Calcium channels
EI-207,Ebselen,274.2,4-B02,4,Plate 4,B02,EnzoICCB1,SP0127,D04,ICCB Known Bioactives Library,18.2361952002334,Inhibitors:  glutathione peroxidase mimetic,DMSO,2840,Ebselen - Inhibitors - glutathione peroxidase mimetic
AC-116,Fluspirilene,475.6,3-B03,3,Plate 3,B03,EnzoICCB1,SP0127,D05,ICCB Known Bioactives Library,10.5136396601403,Ion channel ligands:  Potassium channels,DMSO,2840,Fluspiriline - Ion channel ligands - Potassium channels
CN-266,TRIM,212.2,4-B03,4,Plate 4,B03,EnzoICCB1,SP0127,D06,ICCB Known Bioactives Library,23.5658751046325,Inhibitors:  bNOS/iNOS inhibitor,DMSO,2840,TRIM - Inhibitors - bNOS/iNOS inhibitor
CA-245,FPL-64176,347.4,3-B04,3,Plate 3,B04,EnzoICCB1,SP0127,D07,ICCB Known Bioactives Library,14.3923409718284,Ion channel ligands:  Calcium channels,DMSO,2840,FPL-64176 - Ion channel ligands - Calcium channels
PD-195,Zardaverine,268.2,4-B04,4,Plate 4,B04,EnzoICCB1,SP0127,D08,ICCB Known Bioactives Library,18.6416778703151,Inhibitors:  phosphodiesterase (PDE1/2) inhibitor,DMSO,2840,Zardaverine - Inhibitors - phosphodiesterase (PDE1/2) inhibitor
CA-422,6-Gingerol,294.4,3-B05,3,Plate 3,B05,EnzoICCB1,SP0127,D09,ICCB Known Bioactives Library,16.9845091086224,Ion channel ligands:  Intracellular calcium,DMSO,2840,Gingerol - Ion channel ligands - Intracellular calcium
PD-190,Zaprinast,271.3,4-B05,4,Plate 4,B05,EnzoICCB1,SP0127,D10,ICCB Known Bioactives Library,18.4315081470952,Inhibitors:  phosphodiesterase (PDE1) inhibitor,DMSO,2840,Zaprinast - Inhibitors - phosphodiesterase (PDE1) inhibitor
AC-120,Glipizide,445.5,3-B06,3,Plate 3,B06,EnzoICCB1,SP0127,D11,ICCB Known Bioactives Library,11.222462881704,Ion channel ligands:  Potassium channels,DMSO,2840,Glipizide - Ion channel ligands - Potassium channels
PD-185,Vinpocetine,350.5,4-B06,4,Plate 4,B06,EnzoICCB1,SP0127,D12,ICCB Known Bioactives Library,14.2672076791819,Inhibitors:  phosphodiesterase (PDE1) inhibitor,DMSO,2840,Vinpocetine - Inhibitors - phosphodiesterase (PDE1) inhibitor
KC-120,Glyburide,494.0,3-B07,3,Plate 3,B07,EnzoICCB1,SP0127,D13,ICCB Known Bioactives Library,10.1213755354208,Ion channel ligands:  Potassium channels,DMSO,2840,Glyburide - Ion channel ligands - Potassium channels
PD-180,Trequinsin,405.5,4-B07,4,Plate 4,B07,EnzoICCB1,SP0127,D14,ICCB Known Bioactives Library,12.3307755194647,Inhibitors:  phosphodiesterase (PDE3) inhibitor,DMSO,2840,Trequinsin - Inhibitors - phosphodiesterase (PDE3) inhibitor
NA-135,Grayanotoxin III,370.5,3-B08,3,Plate 3,B08,EnzoICCB1,SP0127,D15,ICCB Known Bioactives Library,13.4959906111093,Ion channel ligands:  Sodium channels,DMSO,2840,Grayanotoxin III - Ion channel ligands - Sodium channels
PD-179,Siguazodan,284.3,4-B08,4,Plate 4,B08,EnzoICCB1,SP0127,D16,ICCB Known Bioactives Library,17.5860414664789,Inhibitors:  phosphodiesterase (PDE3) inhibitor,DMSO,2840,Siguazodan - Inhibitors - phosphodiesterase (PDE3) inhibitor
CM-101,R(+)-IAA-94,357.2,3-B09,3,Plate 3,B09,EnzoICCB1,SP0127,D17,ICCB Known Bioactives Library,13.9966631954942,Ion channel ligands:  Misc. channels,DMSO,2840,IAA-94 - Ion channel ligands - Misc. channels
PD-175,Rolipram,275.3,4-B09,4,Plate 4,B09,EnzoICCB1,SP0127,D18,ICCB Known Bioactives Library,18.1591819361175,Inhibitors:  phosphodiesterase (PDE4 ) inhibitor,DMSO,2840,Rolipram - Inhibitors - phosphodiesterase (PDE4 ) inhibitor
CA-207,L-cis-Diltiazem·HCl,451.0,3-B10,3,Plate 3,B10,EnzoICCB1,SP0127,D19,ICCB Known Bioactives Library,11.0869907467975,Ion channel ligands:  Calcium channels,DMSO,2840,L-cis-Diltiazem - Ion channel ligands - Calcium channels
EI-117,Ro 20-1724,278.3,4-B10,4,Plate 4,B10,EnzoICCB1,SP0127,D20,ICCB Known Bioactives Library,17.9632027384543,Inhibitors:  phosphodiesterase (PDE4 ) inhibitor,DMSO,2840,Ro 20-1724 - Inhibitors - phosphodiesterase (PDE4 ) inhibitor
AC-128,Lidocaine·HCl·H2O,288.8,3-B11,3,Plate 3,B11,EnzoICCB1,SP0127,D21,ICCB Known Bioactives Library,17.3121801574716,Ion channel ligands:  Sodium channels,DMSO,2840,Lidocaine - Ion channel ligands - Sodium channels
PD-155,MY-5445,331.8,4-B11,4,Plate 4,B11,EnzoICCB1,SP0127,D22,ICCB Known Bioactives Library,15.0694097010832,Inhibitors:  phosphodiesterase (PDE5) inhibitor,DMSO,2840,MY-5445 - Inhibitors - phosphodiesterase (PDE5) inhibitor
PG-050,15-deoxy-Prostaglandin J2,316.4,1-C02,1,Plate 1,C02,EnzoICCB1,SP0127,E03,ICCB Known Bioactives Library,1,Bioactive lipids:  Bioactive prostaglandin,DMSO,2840,15d-Prostaglandin J2  - Bioactive lipids - Bioactive prostaglandin
LE-012,Leukotoxin B (12;13-EODE),296.4,2-C02,2,Plate 2,C02,EnzoICCB1,SP0127,E04,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive linoleic acid metabolite,DMSO,2840,Leukotoxin B (12;13-EODE)  - Bioactive lipids - Bioactive linoleic acid metabolite
K-015,15-Ketoicosatetraenoic acid,318.5,1-C03,1,Plate 1,C03,EnzoICCB1,SP0127,E05,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive arachidonic acid metabolite,DMSO,2840,15-Ketoeicosatetraenoic acid - Bioactive lipids - Bioactive arachidonic acid metabolite
LB-004,Leukotriene B4,336.5,2-C03,2,Plate 2,C03,EnzoICCB1,SP0127,E06,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Leukotriene B4 receptor agonist,DMSO,2840,Leukotriene B4   - Bioactive lipids - Leukotriene B4 receptor agonist
PG-021,16;16-Dimethyl-prostaglandin E2,380.5,1-C04,1,Plate 1,C04,EnzoICCB1,SP0127,E07,ICCB Known Bioactives Library,1,Bioactive lipids:  Prostaglandin EP receptor agonist,DMSO,2840,16;16-Dimethyl-prostaglandin E2  - Bioactive lipids - Prostaglandin EP receptor agonist
LC-004,Leukotriene C4,625.8,2-C04,2,Plate 2,C04,EnzoICCB1,SP0127,E08,ICCB Known Bioactives Library,0.1,Bioactive lipids:  CysLT receptor agonist,DMSO,2840,Leukotriene C4  - Bioactive lipids - CysLT receptor agonist
EI-103,17-Octadecynoic acid,280.4,1-C05,1,Plate 1,C05,EnzoICCB1,SP0127,E09,ICCB Known Bioactives Library,1,Lipid biosynthesis:  Inhibits fatty acid omega oxidation,DMSO,2840,17-Octadecynoic acid  - Lipid biosynthesis - Inhibits fatty acid omega oxidation
LD-004,Leukotriene D4,496.7,2-C05,2,Plate 2,C05,EnzoICCB1,SP0127,E10,ICCB Known Bioactives Library,0.1,Bioactive lipids:  CysLT receptor agonist,DMSO,2840,Leukotriene D4  - Bioactive lipids - CysLT receptor agonist
PG-042,17-Phenyl-trinor-prostaglandin E2,386.5,1-C06,1,Plate 1,C06,EnzoICCB1,SP0127,E11,ICCB Known Bioactives Library,1,Bioactive lipids:  Prostaglandin EP1 receptor agonist,DMSO,2840,17-Phenyl-trinor-prostaglandin E2  - Bioactive lipids - Prostaglandin EP1 receptor agonist
LE-004,Leukotriene E4,439.6,2-C06,2,Plate 2,C06,EnzoICCB1,SP0127,E12,ICCB Known Bioactives Library,0.1,Bioactive lipids:  CysLT1 receptor agonist,DMSO,2840,Leukotriene E4  - Bioactive lipids - CysLT1 receptor agonist
L-134,1-Acyl-PAF,537.7,1-C07,1,Plate 1,C07,EnzoICCB1,SP0127,E13,ICCB Known Bioactives Library,1,Bioactive lipids:  PAF agonist,DMSO,2840,1-Acyl-PAF  - Bioactive lipids - PAF agonist
FA-023,Linoleamide,279.5,2-C07,2,Plate 2,C07,EnzoICCB1,SP0127,E14,ICCB Known Bioactives Library,1,Endocannabinoids:  Bioactive linoleic acid metabolite,DMSO,2840,Linoleamide - Endocannabinoids - Bioactive linoleic acid metabolite
DG-140,1-Hexadecyl-2-arachidonoyl-glycerol,603.0,1-C08,1,Plate 1,C08,EnzoICCB1,SP0127,E15,ICCB Known Bioactives Library,1,Bioactive lipids:  DAG analog,DMSO,2840,1-Hexadecyl-2-arachidonoyl-glycerol - Bioactive lipids - DAG analog
FA-014,Linoleic acid,280.4,2-C08,2,Plate 2,C08,EnzoICCB1,SP0127,E16,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid ,DMSO,2840,Linoleic acid - Bioactive lipids - Polyunsaturated fatty acid 
L-106,1-Hexadecyl-2-methylglycero-3 PC,495.7,1-C09,1,Plate 1,C09,EnzoICCB1,SP0127,E17,ICCB Known Bioactives Library,1,Bioactive lipids:  PAF receptor agonist,DMSO,2840,1-Hexadecyl-2-methylglycero-3 PC - Bioactive lipids - PAF receptor agonist
FA-005,Linolenic acid (18:3 n-3),278.4,2-C09,2,Plate 2,C09,EnzoICCB1,SP0127,E18,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid ,DMSO,2840,Linolenic acid (18:3 n-3)  - Bioactive lipids - Polyunsaturated fatty acid 
EI-150,1-Hexadecyl-2-O-acetyl-glycerol,358.6,1-C10,1,Plate 1,C10,EnzoICCB1,SP0127,E19,ICCB Known Bioactives Library,1,Bioactive lipids:  Blocks DAG activation of PKC,DMSO,2840,1-Hexadecyl-2-O-acetyl-glycerol  - Bioactive lipids - Blocks DAG activation of PKC
LXA-004,Lipoxin A4,352.5,2-C10,2,Plate 2,C10,EnzoICCB1,SP0127,E20,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive arachidonic acid metabolite,DMSO,2840,Lipoxin A4 - Bioactive lipids - Bioactive arachidonic acid metabolite
EI-149,1-Hexadecyl-2-O-methyl-glycerol,330.5,1-C11,1,Plate 1,C11,EnzoICCB1,SP0127,E21,ICCB Known Bioactives Library,1,Bioactive lipids:  Blocks DAG activation of PKC,DMSO,2840,1-Hexadecyl-2-O-methyl-glycerol - Bioactive lipids - Blocks DAG activation of PKC
LP-101,L-NASPA,423.5,2-C11,2,Plate 2,C11,EnzoICCB1,SP0127,E22,ICCB Known Bioactives Library,1,Bioactive lipids:  LPA agonist / antagonist,DMSO,2840,L-NASPA - Bioactive lipids - LPA agonist / antagonist
AC-110,Loperamide·HCl,513.5,3-C02,3,Plate 3,C02,EnzoICCB1,SP0127,F03,ICCB Known Bioactives Library,9.73713626927466,Ion channel ligands:  Calcium channels,DMSO,2840,Loperamide - Ion channel ligands - Calcium channels
EI-145,A-3,284.8,4-C02,4,Plate 4,C02,EnzoICCB1,SP0127,F04,ICCB Known Bioactives Library,17.5585225556781,Kinase inhibitors:  kinase inhibitor,DMSO,2840,A-3 - Kinase inhibitors - kinase inhibitor
AC-103,Methoxyverapimil·HCl,521.1,3-C03,3,Plate 3,C03,EnzoICCB1,SP0127,F05,ICCB Known Bioactives Library,9.5952898641115,Ion channel ligands:  Calcium channels,DMSO,2840,Methoxy verapamil - Ion channel ligands - Calcium channels
G-200,Acetyl (N)-s-farnesyl-l-cysteine,367.5,4-C03,4,Plate 4,C03,EnzoICCB1,SP0127,F06,ICCB Known Bioactives Library,13.6037393958851,Inhibitors:  farnesylation inhibitor,DMSO,2840,Acetyl (N)-S-farnesyl-L-cysteine - Inhibitors - farnesylation inhibitor
KC-125,Minoxidil,209.2,3-C04,3,Plate 3,C04,EnzoICCB1,SP0127,F07,ICCB Known Bioactives Library,23.8950567340332,Ion channel ligands:  Potassium channels,DMSO,2840,Minoxidil    - Ion channel ligands - Potassium channels
GR-300,Actinomycin D,464.5,4-C04,4,Plate 4,C04,EnzoICCB1,SP0127,F08,ICCB Known Bioactives Library,10.7640239624396,Inhibitors:  transcription inhibitor,DMSO,2840,Actinomycin D - Inhibitors - transcription inhibitor
KC-130,Minoxidil sulfate,289.3,3-C05,3,Plate 3,C05,EnzoICCB1,SP0127,F09,ICCB Known Bioactives Library,17.2823802676695,Ion channel ligands:  Potassium channels,DMSO,2840,Minoxidil sulfate - Ion channel ligands - Potassium channels
VR-101,Arvanil,439.6,4-C05,4,Plate 4,C05,EnzoICCB1,SP0127,F10,ICCB Known Bioactives Library,11.3732001910698,Ion channel ligands:  Vaniloid receptor agonist,DMSO,2840,Arvanil - Ion channel ligands - Vaniloid receptor agonist
AC-108,Nicardipine·HCl,516.0,3-C06,3,Plate 3,C06,EnzoICCB1,SP0127,F11,ICCB Known Bioactives Library,9.69018539262693,Ion channel ligands:  Calcium channels,DMSO,2840,Nicardipine - Ion channel ligands - Calcium channels
EI-277,AG1478,352.2,4-C06,4,Plate 4,C06,EnzoICCB1,SP0127,F12,ICCB Known Bioactives Library,14.1958746788183,Kinase inhibitors:  Tyrosine kinase inhibitor. Broad spectrum,DMSO,2840,AG1478 - Kinase inhibitors - Tyrosine kinase inhibitor. Broad spectrum
CA-210,Nifedipine,346.3,3-C07,3,Plate 3,C07,EnzoICCB1,SP0127,F13,ICCB Known Bioactives Library,14.436905813049,Ion channel ligands:  Calcium channels,DMSO,2840,Nifedipine - Ion channel ligands - Calcium channels
EI-188,AG213 (Tyrphostin 47),220.2,4-C07,4,Plate 4,C07,EnzoICCB1,SP0127,F14,ICCB Known Bioactives Library,22.7016817405833,Kinase inhibitors:  EGF-R tyrosine kinase inhibitor,DMSO,2840,AG213 (Tyrphostin 47) - Kinase inhibitors - EGF-R tyrosine kinase inhibitor
AC-134,Niflumic acid,282.2,3-C08,3,Plate 3,C08,EnzoICCB1,SP0127,F15,ICCB Known Bioactives Library,17.7168004875664,Ion channel ligands:  Misc. channels,DMSO,2840,Niflumic acid  - Ion channel ligands - Misc. channels
EI-229,AG-370,259.3,4-C08,4,Plate 4,C08,EnzoICCB1,SP0127,F16,ICCB Known Bioactives Library,19.2852500621949,Kinase inhibitors:  PDGF receptor kinase inhibitor,DMSO,2840,AG-370 - Kinase inhibitors - PDGF receptor kinase inhibitor
CA-216,Niguldipine,646.2,3-C09,3,Plate 3,C09,EnzoICCB1,SP0127,F17,ICCB Known Bioactives Library,7.73787784057496,Ion channel ligands:  Calcium channels,DMSO,2840,Niguldipine - Ion channel ligands - Calcium channels
EI-272,AG-490,294.3,4-C09,4,Plate 4,C09,EnzoICCB1,SP0127,F18,ICCB Known Bioactives Library,16.9891952116293,Kinase inhibitors:  JAK2 inhibitor,DMSO,2840,AG-490 - Kinase inhibitors - JAK2 inhibitor
CA-211,Nimodipine,418.4,3-C10,3,Plate 3,C10,EnzoICCB1,SP0127,F19,ICCB Known Bioactives Library,11.949135874341,Ion channel ligands:  Calcium channels,DMSO,2840,Nimodipine - Ion channel ligands - Calcium channels
EI-258,AG-879,316.5,4-C10,4,Plate 4,C10,EnzoICCB1,SP0127,F20,ICCB Known Bioactives Library,15.7997351964381,Kinase inhibitors:  NGF receptor inhibitor,DMSO,2840,AG-879 - Kinase inhibitors - NGF receptor inhibitor
CA-212,Nitrendipine,360.4,3-C11,3,Plate 3,C11,EnzoICCB1,SP0127,F21,ICCB Known Bioactives Library,13.8749676713253,Ion channel ligands:  Calcium channels,DMSO,2840,Nitrendipine - Ion channel ligands - Calcium channels
A-150,Alamethicin,1964.3,4-C11,4,Plate 4,C11,EnzoICCB1,SP0127,F22,ICCB Known Bioactives Library,2.54542592561105,Inhibitors:  monovalent cation ionophore,DMSO,2840,Alamethicin - Inhibitors - monovalent cation ionophore
L-108,1-Octadecyl-2-methylglycero-3 PC,523.7,1-D02,1,Plate 1,D02,EnzoICCB1,SP0127,G03,ICCB Known Bioactives Library,1,Bioactive lipids:  Inhibits PI-specific PLC,DMSO,2840,1-Octadecyl-2-methylglycero-3 PC  - Bioactive lipids - Inhibits PI-specific PLC
RA-101,LY-171883,318.4,2-D02,2,Plate 2,D02,EnzoICCB1,SP0127,G04,ICCB Known Bioactives Library,1,Bioactive lipids:  Leukotriene D4 receptor antagonist,DMSO,2840,LY-171883 - Bioactive lipids - Leukotriene D4 receptor antagonist
DG-125,1-Oleoyl 2-acetyl-glycerol,398.6,1-D03,1,Plate 1,D03,EnzoICCB1,SP0127,G05,ICCB Known Bioactives Library,1,Bioactive lipids:  PKC activator,DMSO,2840,1-Oleoyl-2-acetyl-glycerol - Bioactive lipids - PKC activator
L-101,Lyso-PAF C16,481.6,2-D03,2,Plate 2,D03,EnzoICCB1,SP0127,G06,ICCB Known Bioactives Library,1,Bioactive lipids:  Inactive PAF metabolite,DMSO,2840,Lyso-PAF C16  - Bioactive lipids - Inactive PAF metabolite
DG-135,1-Stearoyl-2-lineoyl-glycerol,621.0,1-D04,1,Plate 1,D04,EnzoICCB1,SP0127,G07,ICCB Known Bioactives Library,1,Bioactive lipids:  PKC activator,DMSO,2840,1-Stearoyl-2-linoleoyl-glycerol  - Bioactive lipids - PKC activator
LP-100,Lysophosphatidic acid·Na,458.5,2-D04,2,Plate 2,D04,EnzoICCB1,SP0127,G08,ICCB Known Bioactives Library,1,Bioactive lipids:  LPA receptor antagonist,DMSO,2840,Lysophosphatidic acid  - Bioactive lipids - LPA receptor antagonist
DG-130,1-stearoyl-2-arachidonyl-glycerol,645.0,1-D05,1,Plate 1,D05,EnzoICCB1,SP0127,G09,ICCB Known Bioactives Library,1,Bioactive lipids:  PKC activator,DMSO,2840,1-Stearoyl-2-arachidonoyl-glycerol - Bioactive lipids - PKC activator
SL-221,D-erythro-MAPP,361.6,2-D05,2,Plate 2,D05,EnzoICCB1,SP0127,G10,ICCB Known Bioactives Library,1,Lipid biosynthesis:  Ceramidase inhibitor,DMSO,2840,MAPP; D-erythro  - Lipid biosynthesis - Ceramidase inhibitor
DM-300,24;25-Dihydroxyvitamin D3,416.6,1-D06,1,Plate 1,D06,EnzoICCB1,SP0127,G11,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  Vitamin D receptor ligand,DMSO,2840,24;25-Dihydroxyvitamin D3  - Nuclear receptor ligands - Vitamin D receptor ligand
SL-222,L-erythro-MAPP,361.6,2-D06,2,Plate 2,D06,EnzoICCB1,SP0127,G12,ICCB Known Bioactives Library,1,Lipid biosynthesis:  Negative control for D-erythro-MAPP,DMSO,2840,MAPP; L-erythro  - Lipid biosynthesis - Negative control for D-erythro-MAPP
DM-100,25-Dihydroxyvitamin D3,400.6,1-D07,1,Plate 1,D07,EnzoICCB1,SP0127,G13,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  Vitamin D receptor ligand,DMSO,2840,25-Hydroxyvitamin D3  - Nuclear receptor ligands - Vitamin D receptor ligand
FA-004,Mead acid (20:3 n-9),306.5,2-D07,2,Plate 2,D07,EnzoICCB1,SP0127,G14,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid ,DMSO,2840,Mead acid (20:3 n-9)  - Bioactive lipids - Polyunsaturated fatty acid 
FA-028,2-Arachidonoylglycerol,378.5,1-D08,1,Plate 1,D08,EnzoICCB1,SP0127,G15,ICCB Known Bioactives Library,1,Endocannabinoids:  Cannabinoid CB1 receptor agonist,DMSO,2840,2-Arachidonoylglycerol - Endocannabinoids - Cannabinoid CB1 receptor agonist
FA-027,Mead ethanolamide,349.6,2-D08,2,Plate 2,D08,EnzoICCB1,SP0127,G16,ICCB Known Bioactives Library,1,Endocannabinoids:  Cannabinoid receptor agonist,DMSO,2840,Mead ethanolamide - Endocannabinoids - Cannabinoid receptor agonist
G-231,2-Fluoropalmitic acid,274.4,1-D09,1,Plate 1,D09,EnzoICCB1,SP0127,G17,ICCB Known Bioactives Library,1,Bioactive lipids:  Protein palmitoylation inhibitor,DMSO,2840,2-Fluoropalmitic acid  - Bioactive lipids - Protein palmitoylation inhibitor
GR-106,Methoprene acid,268.4,2-D09,2,Plate 2,D09,EnzoICCB1,SP0127,G18,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  Retinoid RXR agonist,DMSO,2840,Methoprene acid - Nuclear receptor ligands - Retinoid RXR agonist
G-230,2-Hydroxymyristic acid,244.4,1-D10,1,Plate 1,D10,EnzoICCB1,SP0127,G19,ICCB Known Bioactives Library,1,Bioactive lipids:  Protein myristoylation inhibitor,DMSO,2840,2-Hydroxymyristic acid  - Bioactive lipids - Protein myristoylation inhibitor
PG-052,Misoprostol; free acid,368.5,2-D10,2,Plate 2,D10,EnzoICCB1,SP0127,G20,ICCB Known Bioactives Library,1,Bioactive lipids:  Prostaglandin EP receptor agonist,DMSO,2840,Misoprostol; free acid  - Bioactive lipids - Prostaglandin EP receptor agonist
GR-103,4-hydroxyphenylretinamide,391.5,1-D11,1,Plate 1,D11,EnzoICCB1,SP0127,G21,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  Retinoid receptor agonist / apoptosis inducer,DMSO,2840,4-Hydroxyphenylretinamide - Nuclear receptor ligands - Retinoid receptor agonist / apoptosis inducer
SL-105,N;N-Dimethylsphingosine,327.5,2-D11,2,Plate 2,D11,EnzoICCB1,SP0127,G22,ICCB Known Bioactives Library,1,Lipid biosynthesis:  Sphingosine kinase inhibitor,DMSO,2840,N;N-Dimethylsphingosine  - Lipid biosynthesis - Sphingosine kinase inhibitor
AC-132,N-Phenylanthranilic acid,213.2,3-D02,3,Plate 3,D02,EnzoICCB1,SP0127,H03,ICCB Known Bioactives Library,23.4486490998767,Ion channel ligands:  Misc. channels,DMSO,2840,N-Phenylanthranilic acid - Ion channel ligands - Misc. channels
EI-303,AG-1296,266.3,4-D02,4,Plate 4,D02,EnzoICCB1,SP0127,H04,ICCB Known Bioactives Library,18.7761974895473,Kinase inhibitors:  c-kit; FGF and PDGF kinase inhibitor,DMSO,2840,AG-1296 - Kinase inhibitors - c-kit; FGF and PDGF kinase inhibitor
CM-100,NPPB,300.3,3-D03,3,Plate 3,D03,EnzoICCB1,SP0127,H05,ICCB Known Bioactives Library,16.6495065752231,Ion channel ligands:  Misc. channels,DMSO,2840,NPPB - Ion channel ligands - Misc. channels
PD-152,Milrinone,211.2,4-D03,4,Plate 4,D03,EnzoICCB1,SP0127,H06,ICCB Known Bioactives Library,23.6720680013294,Inhibitors:  phosphodiesterase (PDE3) inhibitor,DMSO,2840,Milrinone - Inhibitors - phosphodiesterase (PDE3) inhibitor
KC-127,NS-1619,362.2,3-D04,3,Plate 3,D04,EnzoICCB1,SP0127,H07,ICCB Known Bioactives Library,13.8035141538473,Ion channel ligands:  Potassium channels,DMSO,2840,NS-1619 - Ion channel ligands - Potassium channels
GR-333,PRIMA-1,185.2,4-D04,4,Plate 4,D04,EnzoICCB1,SP0127,H08,ICCB Known Bioactives Library,26.994881230621,Inhibitors:  p53 reactivator,DMSO,2840,PRIMA-1 - Inhibitors - p53 reactivator
KC-155,Paxilline,435.6,3-D05,3,Plate 3,D05,EnzoICCB1,SP0127,H09,ICCB Known Bioactives Library,11.4796012078377,Ion channel ligands:  Potassium channels,DMSO,2840,Paxilline - Ion channel ligands - Potassium channels
EI-313,Ikarugamycin,480.6,4-D05,4,Plate 4,D05,EnzoICCB1,SP0127,H10,ICCB Known Bioactives Library,10.4028200796898,Inhibitors:  inhibits clathrin coated pit mediated endocytosis,DMSO,2840,Ikarugamyin  - Inhibitors - inhibits clathrin coated pit mediated endocytosis
KC-131,PCO-400,299.3,3-D06,3,Plate 3,D06,EnzoICCB1,SP0127,H11,ICCB Known Bioactives Library,16.7044632989578,Ion channel ligands:  Potassium channels,DMSO,2840,PCO-400 - Ion channel ligands - Potassium channels
AP-101,4-Amino-1;8-naphthalimide,212.2,4-D06,4,Plate 4,D06,EnzoICCB1,SP0127,H12,ICCB Known Bioactives Library,23.5622214650895,Inhibitors:  PARP inhibitor,DMSO,2840,Amino-1;8-naphthalimide [4-Amino-1;8-naphthalimide] - Inhibitors - PARP inhibitor
KC-157,Penitrem A,634.2,3-D07,3,Plate 3,D07,EnzoICCB1,SP0127,H13,ICCB Known Bioactives Library,7.88393584999078,Ion channel ligands:  Potassium channels,DMSO,2840,Penitrem A - Ion channel ligands - Potassium channels
G-400,3-aminobenzamide (3-ABA),136.2,4-D07,4,Plate 4,D07,EnzoICCB1,SP0127,H14,ICCB Known Bioactives Library,36.7238775714059,Inhibitors:  ADP ribose polymerase; apoptosis inhibitor,DMSO,2840,Aminobenzamide (3-ABA) [3-Aminobenzamide (3-ABA)] - Inhibitors - ADP ribose polymerase; apoptosis inhibitor
AC-131,Phenamil,305.7,3-D08,3,Plate 3,D08,EnzoICCB1,SP0127,H15,ICCB Known Bioactives Library,16.3546740022831,Ion channel ligands:  Sodium channels,DMSO,2840,Phenamil - Ion channel ligands - Sodium channels
EI-308,17-Allylamino-geldanamycin,585.7,4-D08,4,Plate 4,D08,EnzoICCB1,SP0127,H16,ICCB Known Bioactives Library,8.53696265795942,Inhibitors:  HSP-90 inhibitor,DMSO,2840,17-Allylamino-geldanamycin - Inhibitors - HSP-90 inhibitor
AC-121,Phentolamine,281.4,3-D09,3,Plate 3,D09,EnzoICCB1,SP0127,H17,ICCB Known Bioactives Library,17.7713137585866,Ion channel ligands:  Potassium channels,DMSO,2840,Phentolamine - Ion channel ligands - Potassium channels
ST-102,Anisomycin,265.3,4-D09,4,Plate 4,D09,EnzoICCB1,SP0127,H18,ICCB Known Bioactives Library,18.846233580219,Inhibitors:  MAP kinase activator,DMSO,2840,Anisomycin - Inhibitors - MAP kinase activator
AC-125,Phenytoin,252.3,3-D10,3,Plate 3,D10,EnzoICCB1,SP0127,H19,ICCB Known Bioactives Library,19.8201912252049,Ion channel ligands:  Sodum channels,DMSO,2840,Phenytoin - Ion channel ligands - Sodum channels
CC-101,Aphidicolin,338.5,4-D10,4,Plate 4,D10,EnzoICCB1,SP0127,H20,ICCB Known Bioactives Library,14.7718517047899,Inhibitors:  DNA polymerase inhibitor,DMSO,2840,Aphidicolin - Inhibitors - DNA polymerase inhibitor
AC-109,Pimozide,461.5,3-D11,3,Plate 3,D11,EnzoICCB1,SP0127,H21,ICCB Known Bioactives Library,10.8331516974899,Ion channel ligands:  Calcium channels,DMSO,2840,Pimozide - Ion channel ligands - Calcium channels
EI-175,Aristolochic acid,341.3,4-D11,4,Plate 4,D11,EnzoICCB1,SP0127,H22,ICCB Known Bioactives Library,14.6510829934038,Lipid biosynthesis:  phospholipase A2 inhibitor,DMSO,2840,Aristolochic acid - Lipid biosynthesis - phospholipase A2 inhibitor
G-232,4-Oxatetradecanoic acid,230.3,1-E02,1,Plate 1,E02,EnzoICCB1,SP0127,I03,ICCB Known Bioactives Library,1,Bioactive lipids:  Myristic acid analog,DMSO,2840,4-Oxatetradecanoic acid - Bioactive lipids - Myristic acid analog
LEA-004,N-Acetyl-leukotriene E4,481.6,2-E02,2,Plate 2,E02,EnzoICCB1,SP0127,I04,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive arachidonic acid metabolite,DMSO,2840,N-Acetyl-leukotriene E4 - Bioactive lipids - Bioactive arachidonic acid metabolite
H-005,5(S)-HETE,320.5,1-E03,1,Plate 1,E03,EnzoICCB1,SP0127,I05,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive arachidonic acid metabolite,DMSO,2840,5(S)-HETE  - Bioactive lipids - Bioactive arachidonic acid metabolite
FA-029,N-arachidonoylglycine,361.5,2-E03,2,Plate 2,E03,EnzoICCB1,SP0127,I06,ICCB Known Bioactives Library,1,Endocannabinoids:  FAAH inhibitor,DMSO,2840,N-Arachidonoylglycine - Endocannabinoids - FAAH inhibitor
HP-005,5(S)-HPETE,336.5,1-E04,1,Plate 1,E04,EnzoICCB1,SP0127,I07,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Fatty acid hydroperoxide,DMSO,2840,5(S)-HPETE  - Bioactive lipids - Fatty acid hydroperoxide
FA-030,N-linoleoylglycine,337.5,2-E04,2,Plate 2,E04,EnzoICCB1,SP0127,I08,ICCB Known Bioactives Library,1,Endocannabinoids:  FAAH inhibitor,DMSO,2840,N-Linoleoylglycine - Endocannabinoids - FAAH inhibitor
EE-56,5;6-Epoxyeicosatrienoic acid,320.5,1-E05,1,Plate 1,E05,EnzoICCB1,SP0127,I09,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive arachidonic acid metabolite,DMSO,2840,5;6-Epoxyeicosatrienoic acid  - Bioactive lipids - Bioactive arachidonic acid metabolite
L-100,PAF C16,523.7,2-E05,2,Plate 2,E05,EnzoICCB1,SP0127,I10,ICCB Known Bioactives Library,1,Bioactive lipids:  PAF receptor agonist,DMSO,2840,PAF C16  - Bioactive lipids - PAF receptor agonist
ET-004,5;8;11;14-Eicosatetraynoic acid,296.4,1-E06,1,Plate 1,E06,EnzoICCB1,SP0127,I11,ICCB Known Bioactives Library,1,Bioactive lipids:  Cyclooxygenase & lipoxygenase inhibitor,DMSO,2840,5;8;11;14-Eicosatetraynoic acid  - Bioactive lipids - Cyclooxygenase & lipoxygenase inhibitor
L-105,PAF C18,551.7,2-E06,2,Plate 2,E06,EnzoICCB1,SP0127,I12,ICCB Known Bioactives Library,1,Bioactive lipids:  PAF receptor agonist,DMSO,2840,PAF C18  - Bioactive lipids - PAF receptor agonist
ET-003,5;8;11-Eicosatriynoic acid,300.4,1-E07,1,Plate 1,E07,EnzoICCB1,SP0127,I13,ICCB Known Bioactives Library,1,Bioactive lipids:  Lipoxygenase inhibitor,DMSO,2840,5;8;11-Eicosatriynoic acid  - Bioactive lipids - Lipoxygenase inhibitor
L-107,PAF C18:1,549.7,2-E07,2,Plate 2,E07,EnzoICCB1,SP0127,I14,ICCB Known Bioactives Library,1,Bioactive lipids:  PAF receptor agonist,DMSO,2840,PAF C18:1  - Bioactive lipids - PAF receptor agonist
K-005,5-Ketoeicosatetraenoic acid,318.5,1-E08,1,Plate 1,E08,EnzoICCB1,SP0127,I15,ICCB Known Bioactives Library,0.1,Bioactive lipids:  5-KETE receptor (R527) agonist,DMSO,2840,5-Ketoeicosatetraenoic acid  - Bioactive lipids - 5-KETE receptor (R527) agonist
FA-018,Palmitylethanolamide,299.5,2-E08,2,Plate 2,E08,EnzoICCB1,SP0127,I16,ICCB Known Bioactives Library,1,Endocannabinoids:  Cannabinoid CB2 receptor agonist,DMSO,2840,Palmitylethanolamide - Endocannabinoids - Cannabinoid CB2 receptor agonist
GR-206,6-Formylindolo [3;2-B] carbazole,284.3,1-E09,1,Plate 1,E09,EnzoICCB1,SP0127,I17,ICCB Known Bioactives Library,1,Bioactive lipids:  AHR agonist,DMSO,2840,6-Formylindolo [3;2-B] carbazole - Bioactive lipids - AHR agonist
LP-103,Dipalmitoylphosphatidic acid,648.9,2-E09,2,Plate 2,E09,EnzoICCB1,SP0127,I18,ICCB Known Bioactives Library,1,Bioactive lipids:  Activates MAP kinase cascade,DMSO,2840,Phosphatidic acid; dipalmitoyl - Bioactive lipids - Activates MAP kinase cascade
PG-017,6-Keto-prostaglandin F1a,370.5,1-E10,1,Plate 1,E10,EnzoICCB1,SP0127,I19,ICCB Known Bioactives Library,1,Bioactive lipids:  Bioactive prostaglandin,DMSO,2840,6-Keto-prostaglandin F1?  - Bioactive lipids - Bioactive prostaglandin
PG-001,Prostaglandin A1,336.5,2-E10,2,Plate 2,E10,EnzoICCB1,SP0127,I20,ICCB Known Bioactives Library,1,Bioactive lipids:  Bioactive prostaglandin,DMSO,2840,Prostaglandin A1  - Bioactive lipids - Bioactive prostaglandin
EI-112,7;7-Dimethyleicosadienoic acid,336.6,1-E11,1,Plate 1,E11,EnzoICCB1,SP0127,I21,ICCB Known Bioactives Library,1,Bioactive lipids:  PLA2 inhibitor,DMSO,2840,7;7-Dimethyleicosadienoic acid - Bioactive lipids - PLA2 inhibitor
PG-002,Prostaglandin A2,334.4,2-E11,2,Plate 2,E11,EnzoICCB1,SP0127,I22,ICCB Known Bioactives Library,1,Bioactive lipids:  Bioactive prostaglandin,DMSO,2840,Prostaglandin A2  - Bioactive lipids - Bioactive prostaglandin
AC-118,Pinacidil,245.3,3-E02,3,Plate 3,E02,EnzoICCB1,SP0127,J03,ICCB Known Bioactives Library,20.3812516941915,Ion channel ligands:  Potassium channels,DMSO,2840,Pinacidil - Ion channel ligands - Potassium channels
PD-150,8-methoxymethyl-IBMX,266.3,4-E02,4,Plate 4,E02,EnzoICCB1,SP0127,J04,ICCB Known Bioactives Library,18.7760776248112,Inhibitors:  phosphodiesterase (PDE1) inhibitor,DMSO,2840,8-Methoxymethyl-IBMX - Inhibitors - phosphodiesterase (PDE1) inhibitor
AC-127,Procainamide,235.3,3-E03,3,Plate 3,E03,EnzoICCB1,SP0127,J05,ICCB Known Bioactives Library,21.2471842169117,Ion channel ligands:  Sodium channels,DMSO,2840,Procainamide - Ion channel ligands - Sodium channels
PD-149,MBCQ,313.7,4-E03,4,Plate 4,E03,EnzoICCB1,SP0127,J06,ICCB Known Bioactives Library,15.9368645175274,Inhibitors:  phosphodiesterase (PDE5) inhibitor,DMSO,2840,MBCQ - Inhibitors - phosphodiesterase (PDE5) inhibitor
AC-124,Propafenone,341.4,3-E04,3,Plate 3,E04,EnzoICCB1,SP0127,J07,ICCB Known Bioactives Library,14.6436897412167,Ion channel ligands:  Potassium channels,DMSO,2840,Propafenone - Ion channel ligands - Potassium channels
G-235,B581,470.7,4-E04,4,Plate 4,E04,EnzoICCB1,SP0127,J08,ICCB Known Bioactives Library,10.6226577039763,Inhibitors:  farnesyltransferase inhibitor,DMSO,2840,B581 - Inhibitors - farnesyltransferase inhibitor
AC-129,Quinidine·HCl·H2O,378.9,3-E05,3,Plate 3,E05,EnzoICCB1,SP0127,J09,ICCB Known Bioactives Library,13.196337752347,Ion channel ligands:  Sodium channels,DMSO,2840,Quinidine - Ion channel ligands - Sodium channels
GR-244,BADGE,340.4,4-E05,4,Plate 4,E05,EnzoICCB1,SP0127,J10,ICCB Known Bioactives Library,14.6880450182705,Nuclear receptor ligands:  PPAR gamma antagonist,DMSO,2840,BADGE - Nuclear receptor ligands - PPAR gamma antagonist
AC-122,Quinine·HCl·2H2O,396.9,3-E06,3,Plate 3,E06,EnzoICCB1,SP0127,J11,ICCB Known Bioactives Library,12.5973777298518,Ion channel ligands:  Potassium channels,DMSO,2840,Quinine - Ion channel ligands - Potassium channels
CM-110,Bafilomycin A1,622.8,4-E06,4,Plate 4,E06,EnzoICCB1,SP0127,J12,ICCB Known Bioactives Library,0.80278779300149,Inhibitors:  vaculolar ATPase inhibitor,DMSO,2840,Bafilomycin A1 - Inhibitors - vaculolar ATPase inhibitor
NA-134,QX-314,343.3,3-E07,3,Plate 3,E07,EnzoICCB1,SP0127,J13,ICCB Known Bioactives Library,14.5644359776523,Ion channel ligands:  Sodium channels,DMSO,2840,QX-314 - Ion channel ligands - Sodium channels
CA-411,BAPTA-AM,764.7,4-E07,4,Plate 4,E07,EnzoICCB1,SP0127,J14,ICCB Known Bioactives Library,6.53864864440736,Inhibitors:  cell permeable Ca++ chelator,DMSO,2840,BAPTA-AM - Inhibitors - cell permeable Ca++ chelator
CA-450,Ryanodine,493.5,3-E08,3,Plate 3,E08,EnzoICCB1,SP0127,J15,ICCB Known Bioactives Library,10.13075358421,Ion channel ligands:  Intracellular calcium,DMSO,2840,Ryanodine - Ion channel ligands - Intracellular calcium
EI-315,Blebbistatin,292.3,4-E08,4,Plate 4,E08,EnzoICCB1,SP0127,J16,ICCB Known Bioactives Library,17.1038525401616,Inhibitors:  Myosin II inhibitor,DMSO,2840,Blebbistatin - Inhibitors - Myosin II inhibitor
NA-116,SDZ-201106,466.6,3-E09,3,Plate 3,E09,EnzoICCB1,SP0127,J17,ICCB Known Bioactives Library,10.7164113910309,Ion channel ligands:  Sodium channels,DMSO,2840,SDZ-201106 - Ion channel ligands - Sodium channels
CM-113,Bongkrekic acid,486.6,4-E09,4,Plate 4,E09,EnzoICCB1,SP0127,J18,ICCB Known Bioactives Library,1.0275441427826,Inhibitors:  ANT inhibitor,DMSO,2840,Bongkrekic acid - Inhibitors - ANT inhibitor
CA-230,SKF-96365,366.5,3-E10,3,Plate 3,E10,EnzoICCB1,SP0127,J19,ICCB Known Bioactives Library,13.6442996572006,Ion channel ligands:  Calcium channels,DMSO,2840,SKF-96365 - Ion channel ligands - Calcium channels
AC-582 ,IB-MECA,510.3,4-E10,4,Plate 4,E10,EnzoICCB1,SP0127,J20,ICCB Known Bioactives Library,9.79843252515208,CNS receptor ligands:  Adenosine receptor agonist,DMSO,2840,IB-MECA - CNS receptor ligands - Adenosine receptor agonist
CA-260,Tetrandine,622.7,3-E11,3,Plate 3,E11,EnzoICCB1,SP0127,J21,ICCB Known Bioactives Library,8.02890534386276,Ion channel ligands:  Calcium channels,DMSO,2840,Tetrandrine - Ion channel ligands - Calcium channels
G-405,Brefeldin A,280.4,4-E11,4,Plate 4,E11,EnzoICCB1,SP0127,J22,ICCB Known Bioactives Library,17.8342513216964,Inhibitors:  ARF GEF inhibitor,DMSO,2840,Brefeldin A - Inhibitors - ARF GEF inhibitor
EE-89,8;9-Epoxyeicosatrienoic acid,320.5,1-F02,1,Plate 1,F02,EnzoICCB1,SP0127,K03,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive arachidonic acid metabolite,DMSO,2840,8;9-Epoxyeicosatrienoic acid  - Bioactive lipids - Bioactive arachidonic acid metabolite
PG-003,Prostaglandin B1,336.5,2-F02,2,Plate 2,F02,EnzoICCB1,SP0127,K04,ICCB Known Bioactives Library,1,Bioactive lipids:  Bioactive prostaglandin,DMSO,2840,Prostaglandin B1 - Bioactive lipids - Bioactive prostaglandin
PG-049,8-epi-Prostaglandin F2a,354.5,1-F03,1,Plate 1,F03,EnzoICCB1,SP0127,K05,ICCB Known Bioactives Library,1,Bioactive lipids:  Thromboxane TP receptor agonist,DMSO,2840,8-EPI-prostaglandin F2?  - Bioactive lipids - Thromboxane TP receptor agonist
PG-004,Prostaglandin B2,334.4,2-F03,2,Plate 2,F03,EnzoICCB1,SP0127,K06,ICCB Known Bioactives Library,1,Bioactive lipids:  Bioactive prostaglandin,DMSO,2840,Prostaglandin B2 - Bioactive lipids - Bioactive prostaglandin
HO-409,9(S)-HODE,296.4,1-F04,1,Plate 1,F04,EnzoICCB1,SP0127,K07,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Bioactive linoleic acid metabolite,DMSO,2840,9(S)-HODE  - Bioactive lipids - Bioactive linoleic acid metabolite
PG-005,Prostaglandin  D2,352.5,2-F04,2,Plate 2,F04,EnzoICCB1,SP0127,K08,ICCB Known Bioactives Library,1,Bioactive lipids:  Prostaglandin DP receptor agonist,DMSO,2840,Prostaglandin D2 - Bioactive lipids - Prostaglandin DP receptor agonist
HP-019,9(S)-HPODE,312.4,1-F05,1,Plate 1,F05,EnzoICCB1,SP0127,K09,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Fatty acid hydroperoxide,DMSO,2840,9(S)-HPODE  - Bioactive lipids - Fatty acid hydroperoxide
PG-006,Prostaglandin  E1,354.5,2-F05,2,Plate 2,F05,EnzoICCB1,SP0127,K10,ICCB Known Bioactives Library,1,Bioactive lipids:  Prostaglandin EP receptor agonist,DMSO,2840,Prostaglandin E1 - Bioactive lipids - Prostaglandin EP receptor agonist
FA-025,9;10-Octadecenoamide,281.5,1-F06,1,Plate 1,F06,EnzoICCB1,SP0127,K11,ICCB Known Bioactives Library,1,Endocannabinoids:  Endogenous sleep inducing lipid,DMSO,2840,9;10-Octadecenoamide - Endocannabinoids - Endogenous sleep inducing lipid
PG-007,Prostaglandin  E2,352.5,2-F06,2,Plate 2,F06,EnzoICCB1,SP0127,K12,ICCB Known Bioactives Library,1,Bioactive lipids:  Prostaglandin EP receptor agonist,DMSO,2840,Prostaglandin E2 - Bioactive lipids - Prostaglandin EP receptor agonist
PG-031,9a;11b-Prostaglandin F2,354.5,1-F07,1,Plate 1,F07,EnzoICCB1,SP0127,K13,ICCB Known Bioactives Library,1,Bioactive lipids:  Bioactive prostaglandin,DMSO,2840,9alpha;11beta-Prostaglandin F2  - Bioactive lipids - Bioactive prostaglandin
PG-010,Prostaglandin  F1a,356.5,2-F07,2,Plate 2,F07,EnzoICCB1,SP0127,K14,ICCB Known Bioactives Library,1,Bioactive lipids:  Prostaglandin FP receptor agonist,DMSO,2840,Prostaglandin F1? - Bioactive lipids - Prostaglandin FP receptor agonist
PG-030,9b;11a-Prostaglandin F2,354.5,1-F08,1,Plate 1,F08,EnzoICCB1,SP0127,K15,ICCB Known Bioactives Library,1,Bioactive lipids:  Bioactive prostaglandin,DMSO,2840,9beta;11alpha-Prostaglandin F2   - Bioactive lipids - Bioactive prostaglandin
PG-008,Prostaglandin F2a,354.5,2-F08,2,Plate 2,F08,EnzoICCB1,SP0127,K16,ICCB Known Bioactives Library,1,Bioactive lipids:  Prostaglandin FP receptor agonist,DMSO,2840,Prostaglandin F2? - Bioactive lipids - Prostaglandin FP receptor agonist
GR-101,9-cis Retinoic acid,300.4,1-F09,1,Plate 1,F09,EnzoICCB1,SP0127,K17,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  Retinoid RXR agonist,DMSO,2840,9-cis Retinoic acid  - Nuclear receptor ligands - Retinoid RXR agonist
PG-011,Prostaglandin I2 ,352.5,2-F09,2,Plate 2,F09,EnzoICCB1,SP0127,K18,ICCB Known Bioactives Library,1,Bioactive lipids:  Prostaglandin IP receptor agonist,DMSO,2840,Prostaglandin I2 Na - Bioactive lipids - Prostaglandin IP receptor agonist
EI-347,Dimethyloxaloylglycine,175.1,1-F10,1,Plate 1,F10,EnzoICCB1,SP0127,K19,ICCB Known Bioactives Library,1,Inhibitor:  Prolyl-4-hydroxylase inhibitor,DMSO,2840,Dimethyloxaloylglycine - Inhibitor - Prolyl-4-hydroxylase inhibitor
PG-033,Prostaglandin J2,334.4,2-F10,2,Plate 2,F10,EnzoICCB1,SP0127,K20,ICCB Known Bioactives Library,1,Bioactive lipids:  Bioactive prostaglandin,DMSO,2840,Prostaglandin J2 - Bioactive lipids - Bioactive prostaglandin
FA-011,Adrenic acid (22:4; n-6),332.5,1-F11,1,Plate 1,F11,EnzoICCB1,SP0127,K21,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid,DMSO,2840,Adrenic acid (22:4; n-6)  - Bioactive lipids - Polyunsaturated fatty acid
GR-100,All trans retinoic acid,300.4,2-F11,2,Plate 2,F11,EnzoICCB1,SP0127,K22,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  Retinoid RAR agonist,DMSO,2840,Retinoic acid; all trans - Nuclear receptor ligands - Retinoid RAR agonist
PE-180,Thapsigargin,650.8,3-F02,3,Plate 3,F02,EnzoICCB1,SP0127,L03,ICCB Known Bioactives Library,7.68339967692841,Ion channel ligands:  Intracellular calcium,DMSO,2840,Thapsigargin - Ion channel ligands - Intracellular calcium
CN-252,Bromo-7-nitroindazole,242.0,4-F02,4,Plate 4,F02,EnzoICCB1,SP0127,L04,ICCB Known Bioactives Library,20.658596041813,Inhibitors:  NO synthase inhibitor,DMSO,2840,Bromo-7-nitroindazole [3-Bromo-7-nitroindazole] - Inhibitors - NO synthase inhibitor
EI-110,TMB-8,395.5,3-F03,3,Plate 3,F03,EnzoICCB1,SP0127,L05,ICCB Known Bioactives Library,12.6411734649633,Ion channel ligands:  Intracellular calcium,DMSO,2840,TMB-8 - Ion channel ligands - Intracellular calcium
CN-115,8-Bromo-cAMP,408.1,4-F03,4,Plate 4,F03,EnzoICCB1,SP0127,L06,ICCB Known Bioactives Library,12.2518390010341,Activators:  PKA activator,DMSO,2840,Bromo-cAMP [8-Bromo-cAMP] - Activators - PKA activator
KC-135,Tolazamide,311.4,3-F04,3,Plate 3,F04,EnzoICCB1,SP0127,L07,ICCB Known Bioactives Library,16.0565189466924,Ion channel ligands:  Potassium channels,DMSO,2840,Tolazamide - Ion channel ligands - Potassium channels
CN-205,8-Bromo-cGMP,426.1,4-F04,4,Plate 4,F04,EnzoICCB1,SP0127,L08,ICCB Known Bioactives Library,11.733866520228,Activators:  PKG activator,DMSO,2840,Bromo-cGMP [8-Bromo-cGMP] - Activators - PKG activator
AC-117,Tolbutamide,270.3,3-F05,3,Plate 3,F05,EnzoICCB1,SP0127,L09,ICCB Known Bioactives Library,18.4946809297646,Ion channel ligands:  Potassium channels,DMSO,2840,Tolbutamide - Ion channel ligands - Potassium channels
EI-168,Bumetanide,364.4,4-F05,4,Plate 4,F05,EnzoICCB1,SP0127,L10,ICCB Known Bioactives Library,13.7205830698981,Inhibitors:  Na+K+Cl- cotransport inhibitor,DMSO,2840,Bumetanide - Inhibitors - Na+K+Cl- cotransport inhibitor
KC-159,U-37883A,345.5,3-F06,3,Plate 3,F06,EnzoICCB1,SP0127,L11,ICCB Known Bioactives Library,14.4708543968678,Ion channel ligands:  Potassium channels,DMSO,2840,U-37883A - Ion channel ligands - Potassium channels
AC-601,5'-N-Ethylcarboxamidoadenosine (NECA),308.3,4-F06,4,Plate 4,F06,EnzoICCB1,SP0127,L12,ICCB Known Bioactives Library,16.218327228755,CNS receptor ligands:  adenosine receptor agonist,DMSO,2840,5'-N-Ethylcarboxamidoadenosine (NECA) - CNS receptor ligands - adenosine receptor agonist
N-701,U-50488,369.3,3-F07,3,Plate 3,F07,EnzoICCB1,SP0127,L13,ICCB Known Bioactives Library,13.5380649772967,Ion channel ligands:  Calcium channels,DMSO,2840,U-50488 - Ion channel ligands - Calcium channels
EI-304,BW-B 70C,316.3,4-F07,4,Plate 4,F07,EnzoICCB1,SP0127,L14,ICCB Known Bioactives Library,15.8064331550684,Lipid biosynthesis:  5 lipoxygenase inhibitor,DMSO,2840,BW-B 70C - Lipid biosynthesis - 5 lipoxygenase inhibitor
CA-215,Verapimil,454.6,3-F08,3,Plate 3,F08,EnzoICCB1,SP0127,L15,ICCB Known Bioactives Library,10.9986414478084,Ion channel ligands:  Calcium channels,DMSO,2840,Verapamil - Ion channel ligands - Calcium channels
PI-126,CA-074-Me,397.5,4-F08,4,Plate 4,F08,EnzoICCB1,SP0127,L16,ICCB Known Bioactives Library,12.5796955160179,Protease inhibitors:  Cathepsin B inhibitor,DMSO,2840,CA-074-Me - Protease inhibitors - Cathepsin B inhibitor
NA-125,Veratridine,673.8,3-F09,3,Plate 3,F09,EnzoICCB1,SP0127,L17,ICCB Known Bioactives Library,7.42070751400065,Ion channel ligands:  Sodium channels,DMSO,2840,Veratridine - Ion channel ligands - Sodium channels
EI-311,SB-415286,359.7,4-F09,4,Plate 4,F09,EnzoICCB1,SP0127,L18,ICCB Known Bioactives Library,13.8996611262617,Kinase inhibitors:  GSK3 beta inhibitor,DMSO,2840,SB-415286 - Kinase inhibitors - GSK3 beta inhibitor
AC-106,YS035,359.5,3-F10,3,Plate 3,F10,EnzoICCB1,SP0127,L19,ICCB Known Bioactives Library,13.9097806065944,Ion channel ligands:  Calcium channels,DMSO,2840,YS035 - Ion channel ligands - Calcium channels
PI-101,Calpeptin,362.5,4-F10,4,Plate 4,F10,EnzoICCB1,SP0127,L20,ICCB Known Bioactives Library,13.7945038282507,Protease inhibitors:  Calpain inhibitor,DMSO,2840,Calpeptin - Protease inhibitors - Calpain inhibitor
KC-170,ZM226600,373.3,3-F11,3,Plate 3,F11,EnzoICCB1,SP0127,L21,ICCB Known Bioactives Library,13.3923668865693,Ion channel ligands:  Potassium channels,DMSO,2840,ZM226600 - Ion channel ligands - Potassium channels
EI-198,Calphostin C,790.8,4-F11,4,Plate 4,F11,EnzoICCB1,SP0127,L22,ICCB Known Bioactives Library,0.63229982241227,Kinase inhibitors:  PKC inhibitor,DMSO,2840,Calphostin C - Kinase inhibitors - PKC inhibitor
G-221,N-Acetyl-S-geranyl-L-cysteine,299.4,1-G02,1,Plate 1,G02,EnzoICCB1,SP0127,M03,ICCB Known Bioactives Library,1,Bioactive lipids:  Negative control for AGGC and AFC,DMSO,2840,AGC - Bioactive lipids - Negative control for AGGC and AFC
EI-209,REV-5901,335.4,2-G02,2,Plate 2,G02,EnzoICCB1,SP0127,M04,ICCB Known Bioactives Library,1,Lipid biosynthesis:  5-Lipoxygenase inhibitor,DMSO,2840,REV-5901 - Lipid biosynthesis - 5-Lipoxygenase inhibitor
G-220,N-acetyl-S-geranylgeranyl-L-Cysteine,435.7,1-G03,1,Plate 1,G03,EnzoICCB1,SP0127,M05,ICCB Known Bioactives Library,1,Bioactive lipids:  ICMT inhibitor,DMSO,2840,AGGC - Bioactive lipids - ICMT inhibitor
G-201,S-farnesyl-L-cysteine,339.5,2-G03,2,Plate 2,G03,EnzoICCB1,SP0127,M06,ICCB Known Bioactives Library,1,Bioactive lipids:  MDR ATPase activator,DMSO,2840,S-Farnesyl-L-cysteine methyl ester - Bioactive lipids - MDR ATPase activator
CR-108,AM-251,555.2,1-G04,1,Plate 1,G04,EnzoICCB1,SP0127,M07,ICCB Known Bioactives Library,1,CNS receptor ligands:  Cannabinoid CB1 receptor antagonist,DMSO,2840,AM-251 - CNS receptor ligands - Cannabinoid CB1 receptor antagonist
EI-155,Sphingosine,299.5,2-G04,2,Plate 2,G04,EnzoICCB1,SP0127,M08,ICCB Known Bioactives Library,1,Bioactive lipids:  PKC inhibitor,DMSO,2840,Sphingosine   - Bioactive lipids - PKC inhibitor
GR-104,AM-580,351.4,1-G05,1,Plate 1,G05,EnzoICCB1,SP0127,M09,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  Retinoid RAR agonist,DMSO,2840,AM-580  - Nuclear receptor ligands - Retinoid RAR agonist
RA-103,SQ-29548,387.5,2-G05,2,Plate 2,G05,EnzoICCB1,SP0127,M10,ICCB Known Bioactives Library,1,Bioactive lipids:  Thromboxane A2 antagonist,DMSO,2840,SQ-29548 - Bioactive lipids - Thromboxane A2 antagonist
FA-026,Anandamide (18:2;n-6),323.5,1-G06,1,Plate 1,G06,EnzoICCB1,SP0127,M11,ICCB Known Bioactives Library,1,Endocannabinoids:  Cannabinoid receptor agonist,DMSO,2840,Anandamide (18:2;n-6)  - Endocannabinoids - Cannabinoid receptor agonist
L-126,TETRAHYDROCANNABINOL-7-OIC ACID,344.4,2-G06,2,Plate 2,G06,EnzoICCB1,SP0127,M12,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  PPAR gamma agonist,DMSO,2840,Tetrahydrocannabinol-7-oic acid - Nuclear receptor ligands - PPAR gamma agonist
FA-019,Anandamide (20:3;n-6),349.6,1-G07,1,Plate 1,G07,EnzoICCB1,SP0127,M13,ICCB Known Bioactives Library,1,Endocannabinoids:  Cannabinoid receptor agonist,DMSO,2840,Anandamide (20:3;n-6)  - Endocannabinoids - Cannabinoid receptor agonist
GR-105,TTNPB,348.5,2-G07,2,Plate 2,G07,EnzoICCB1,SP0127,M14,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  Retinoid RAR agonist,DMSO,2840,TTNPB  - Nuclear receptor ligands - Retinoid RAR agonist
FA-017,Anandamide (20:4; n-6),347.5,1-G08,1,Plate 1,G08,EnzoICCB1,SP0127,M15,ICCB Known Bioactives Library,1,Endocannabinoids:  Cannabinoid receptor agonist,DMSO,2840,Anandamide (20:4; n-6)  - Endocannabinoids - Cannabinoid receptor agonist
PG-023,U-46619,350.5,2-G08,2,Plate 2,G08,EnzoICCB1,SP0127,M16,ICCB Known Bioactives Library,1,Bioactive lipids:  Thromboxane TP receptor agonist,DMSO,2840,U-46619  - Bioactive lipids - Thromboxane TP receptor agonist
FA-020,Anandamide (22:4;n-6),375.6,1-G09,1,Plate 1,G09,EnzoICCB1,SP0127,M17,ICCB Known Bioactives Library,1,Endocannabinoids:  Cannabinoid receptor agonist,DMSO,2840,Anandamide (22:4;n-6)  - Endocannabinoids - Cannabinoid receptor agonist
RA-102,U-75302,361.5,2-G09,2,Plate 2,G09,EnzoICCB1,SP0127,M18,ICCB Known Bioactives Library,0.1,Bioactive lipids:  Leukotriene B4 receptor antagonist,DMSO,2840,U-75302 - Bioactive lipids - Leukotriene B4 receptor antagonist
FA-022,Arachidonamide,303.5,1-G10,1,Plate 1,G10,EnzoICCB1,SP0127,M19,ICCB Known Bioactives Library,1,Endocannabinoids:  Bioactive arachidonic acid metabolite,DMSO,2840,Arachidonamide  - Endocannabinoids - Bioactive arachidonic acid metabolite
CR-105,WIN 55;212-2 mesylate,522.6,2-G10,2,Plate 2,G10,EnzoICCB1,SP0127,M20,ICCB Known Bioactives Library,1,CNS receptor ligands:  Cannabinoid CB1/CB2 receptor agonist,DMSO,2840,WIN 55;212-2 - CNS receptor ligands - Cannabinoid CB1/CB2 receptor agonist
FA-003,Arachidonic acid (20:4; n-6),304.5,1-G11,1,Plate 1,G11,EnzoICCB1,SP0127,M21,ICCB Known Bioactives Library,1,Bioactive lipids:  Polyunsaturated fatty acid,DMSO,2840,Arachidonic acid (20:4; n-6)  - Bioactive lipids - Polyunsaturated fatty acid
GR-200,WY-14643,323.8,2-G11,2,Plate 2,G11,EnzoICCB1,SP0127,M22,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  PPAR alpha agonist,DMSO,2840,WY-14643  - Nuclear receptor ligands - PPAR alpha agonist
PI-122,Tosyl-Phe-CMK (TPCK),351.8,3-G02,3,Plate 3,G02,EnzoICCB1,SP0127,N03,ICCB Known Bioactives Library,14.2106818853596,Protease inhibitors:  Serine protease inhibitor,DMSO,2840,Tosyl-Phe-CMK (TPCK) - Protease inhibitors - Serine protease inhibitor
EI-192,Calyculin A,1009.2,4-G02,4,Plate 4,G02,EnzoICCB1,SP0127,N04,ICCB Known Bioactives Library,0.49545680969217,Inhibitors:  PP1; PP2A inhibitor,DMSO,2840,Calyculin A - Inhibitors - PP1; PP2A inhibitor
PI-113,Thiorphan,253.3,3-G03,3,Plate 3,G03,EnzoICCB1,SP0127,N05,ICCB Known Bioactives Library,19.7381146942369,Protease inhibitors:  Neutral endopeptidase inhibitor,DMSO,2840,Thiorphan - Protease inhibitors - Neutral endopeptidase inhibitor
GR-301,Camptothecin,348.4,4-G03,4,Plate 4,G03,EnzoICCB1,SP0127,N06,ICCB Known Bioactives Library,14.3532978137057,Inhibitors:  Topoisomerase 1 inhibitor,DMSO,2840,Camptothecin - Inhibitors - Topoisomerase 1 inhibitor
PI-112,Z-prolyl-prolinal,330.4,3-G04,3,Plate 3,G04,EnzoICCB1,SP0127,N07,ICCB Known Bioactives Library,15.1341658940675,Protease inhibitors:  Prolyl endopeptidase inhibitor,DMSO,2840,Z-Prolyl-prolinal - Protease inhibitors - Prolyl endopeptidase inhibitor
PR-105,Cantharidin,196.2,4-G04,4,Plate 4,G04,EnzoICCB1,SP0127,N08,ICCB Known Bioactives Library,25.4842127850218,Inhibitors:  PP2A inhibitor,DMSO,2840,Cantharidin - Inhibitors - PP2A inhibitor
PI-125,NapSul-Ile-Trp-CHO,491.6,3-G05,3,Plate 3,G05,EnzoICCB1,SP0127,N09,ICCB Known Bioactives Library,10.1708292480503,Protease inhibitors:  Cathepsin L inhibitor,DMSO,2840,NapSul-Ile-Trp-CHO - Protease inhibitors - Cathepsin L inhibitor
EI-125,E-Capsaicin,305.4,4-G05,4,Plate 4,G05,EnzoICCB1,SP0127,N10,ICCB Known Bioactives Library,16.3713332715588,Ion channel ligands:  vanilloid receptor agonist,DMSO,2840,Capsacin(E) - Ion channel ligands - vanilloid receptor agonist
PI-110,3;4-dichloroisocoumarin,215.0,3-G06,3,Plate 3,G06,EnzoICCB1,SP0127,N11,ICCB Known Bioactives Library,23.2522450042552,Protease inhibitors:  Granzyme B inhibitor,DMSO,2840,3;4-Dichloroisocoumarin - Protease inhibitors - Granzyme B inhibitor
NK-101,Capsazepine,376.9,4-G06,4,Plate 4,G06,EnzoICCB1,SP0127,N12,ICCB Known Bioactives Library,13.2661183337755,Ion channel ligands:  vanilloid receptor antagonist,DMSO,2840,Capsazepine - Ion channel ligands - vanilloid receptor antagonist
PI-128,Boc-GVV-CHO,357.4,3-G07,3,Plate 3,G07,EnzoICCB1,SP0127,N13,ICCB Known Bioactives Library,13.9881620981796,Protease inhibitors:  Gamma secretase inhibitor,DMSO,2840,Boc-GVV-CHO  - Protease inhibitors - Gamma secretase inhibitor
S-107,Castanospermine,189.2,4-G07,4,Plate 4,G07,EnzoICCB1,SP0127,N14,ICCB Known Bioactives Library,26.4258042693529,Inhibitors:  glucosidase inhibitor,DMSO,2840,Castanospermine - Inhibitors - glucosidase inhibitor
EI-212,Bestatin,308.4,3-G08,3,Plate 3,G08,EnzoICCB1,SP0127,N15,ICCB Known Bioactives Library,16.214140806193,Protease inhibitors:  Aminopeptidase inhibitor,DMSO,2840,Bestatin - Protease inhibitors - Aminopeptidase inhibitor
EI-127,Dipyridamole,504.6,4-G08,4,Plate 4,G08,EnzoICCB1,SP0127,N16,ICCB Known Bioactives Library,9.9083360019785,Inhibitors:  cGMP phosphodiesterase inhibitor,DMSO,2840,Dipyridamole - Inhibitors - cGMP phosphodiesterase inhibitor
PI-123,Ala-Ala-Phe-CMK,339.8,3-G09,3,Plate 3,G09,EnzoICCB1,SP0127,N17,ICCB Known Bioactives Library,14.7138018404023,Protease inhibitors:  Tripeptidyl peptidase II inhibitor,DMSO,2840,Ala-Ala-Phe-CMK - Protease inhibitors - Tripeptidyl peptidase II inhibitor
CM-119,CGP-37157,324.2,4-G09,4,Plate 4,G09,EnzoICCB1,SP0127,N18,ICCB Known Bioactives Library,15.421389467191,Inhibitors:  inhibitor of mitochondrial Na+Ca+2 exchange,DMSO,2840,CGP-37157 - Inhibitors - inhibitor of mitochondrial Na+Ca+2 exchange
PI-130,MDL-28170,382.5,3-G10,3,Plate 3,G10,EnzoICCB1,SP0127,N19,ICCB Known Bioactives Library,13.073508678718,Protease inhibitors:  Calpain inhibitor,DMSO,2840,MDL-28170 - Protease inhibitors - Calpain inhibitor
EI-225,Chelerythrine,348.4,4-G10,4,Plate 4,G10,EnzoICCB1,SP0127,N20,ICCB Known Bioactives Library,14.3524779122541,Kinase inhibitors:  PKC inhibitor,DMSO,2840,Chelerythrine - Kinase inhibitors - PKC inhibitor
P-120,Ac-Leu-Leu-Nle-CHO,383.5,3-G11,3,Plate 3,G11,EnzoICCB1,SP0127,N21,ICCB Known Bioactives Library,13.0369427847692,Protease inhibitors:  Calpain inhibitor,DMSO,2840,Ac-Leu-Leu-Nle-CHO - Protease inhibitors - Calpain inhibitor
FR-102,CAPE,284.3,4-G11,4,Plate 4,G11,EnzoICCB1,SP0127,N22,ICCB Known Bioactives Library,17.5866538401338,Inhibitors:  Antioxidant/ NFkappa B inhibitor,DMSO,2840,CAPE - Inhibitors - Antioxidant/ NFkappa B inhibitor
L-102,Arachidonoyl-PAF,768.1,1-H02,1,Plate 1,H02,EnzoICCB1,SP0127,O03,ICCB Known Bioactives Library,1,Bioactive lipids:  PAF precursor,DMSO,2840,Arachidonoyl-PAF  - Bioactive lipids - PAF precursor
AC-119,4-Aminopyridine,94.1,2-H02,2,Plate 2,H02,EnzoICCB1,SP0127,O04,ICCB Known Bioactives Library,53.1267764265868,Ion channel ligands:  Potassium channels,DMSO,2840,4-Aminopyridine - Ion channel ligands - Potassium channels
CR-104,BML-190,426.9,1-H03,1,Plate 1,H03,EnzoICCB1,SP0127,O05,ICCB Known Bioactives Library,1,Bioactive lipids:  Cannabinoid CB1 inverse agonist,DMSO,2840,BML-190  - Bioactive lipids - Cannabinoid CB1 inverse agonist
KC-141,5-Hydroxydecanoate,188.3,2-H03,2,Plate 2,H03,EnzoICCB1,SP0127,O06,ICCB Known Bioactives Library,26.5584498363999,Ion channel ligands:  Potassium channels,DMSO,2840,5-Hydroxydecanoate - Ion channel ligands - Potassium channels
SL-100,C2 Ceramide,341.5,1-H04,1,Plate 1,H04,EnzoICCB1,SP0127,O07,ICCB Known Bioactives Library,1,Bioactive lipids:  Apoptosis inducer,DMSO,2840,C2 Ceramide - Bioactive lipids - Apoptosis inducer
AC-126,Aconitine,645.7,2-H04,2,Plate 2,H04,EnzoICCB1,SP0127,O08,ICCB Known Bioactives Library,7.74308925412524,Ion channel ligands:  Sodium channels,DMSO,2840,Aconitine - Ion channel ligands - Sodium channels
SL-101,C2 Dihydroceramide,343.5,1-H05,1,Plate 1,H05,EnzoICCB1,SP0127,O09,ICCB Known Bioactives Library,1,Bioactive lipids:  Negative control for C2 ceramide,DMSO,2840,C2 Dihydroceramide - Bioactive lipids - Negative control for C2 ceramide
AC-115,AM 92016·HCl,483.8,2-H05,2,Plate 2,H05,EnzoICCB1,SP0127,O10,ICCB Known Bioactives Library,10.33405878426,Ion channel ligands:  Potassium channels,DMSO,2840,AM 92016 - Ion channel ligands - Potassium channels
SL-112,C8 Ceramide,425.7,1-H06,1,Plate 1,H06,EnzoICCB1,SP0127,O11,ICCB Known Bioactives Library,1,Bioactive lipids:  Stimulates Cer-activated PK,DMSO,2840,C8 Ceramide - Bioactive lipids - Stimulates Cer-activated PK
AC-133,Amantadine·HCl,187.7,2-H06,2,Plate 2,H06,EnzoICCB1,SP0127,O12,ICCB Known Bioactives Library,26.6368334132438,Ion channel ligands:  Misc. channels,DMSO,2840,Amantidine - Ion channel ligands - Misc. channels
SL-113,C8 Dihydroceramide,427.7,1-H07,1,Plate 1,H07,EnzoICCB1,SP0127,O13,ICCB Known Bioactives Library,1,Bioactive lipids:  Negative control for C8 ceramide,DMSO,2840,C8 Dihydroceramide  - Bioactive lipids - Negative control for C8 ceramide
CA-200,Amiloride·HCl,266.1,2-H07,2,Plate 2,H07,EnzoICCB1,SP0127,O14,ICCB Known Bioactives Library,18.790775983885,Ion channel ligands:  Calcium channels,DMSO,2840,Amiloride - Ion channel ligands - Calcium channels
PG-035,Carbacyclin,350.5,1-H08,1,Plate 1,H08,EnzoICCB1,SP0127,O15,ICCB Known Bioactives Library,1,Bioactive lipids:  PPAR delta agonist,DMSO,2840,Carbacyclin - Bioactive lipids - PPAR delta agonist
AC-105,Amiodarone·HCl,681.8,2-H08,2,Plate 2,H08,EnzoICCB1,SP0127,O16,ICCB Known Bioactives Library,7.33381932109368,Ion channel ligands:  Calcium channels,DMSO,2840,Amiodarone  - Ion channel ligands - Calcium channels
GR-205,Ciglitazone,333.4,1-H09,1,Plate 1,H09,EnzoICCB1,SP0127,O17,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  PPAR gamma agonist,DMSO,2840,Ciglitazone  - Nuclear receptor ligands - PPAR gamma agonist
CA-100,A-23187,523.6,2-H09,2,Plate 2,H09,EnzoICCB1,SP0127,O18,ICCB Known Bioactives Library,9.54889857274523,Ion channel ligands:  Calcium ionophore,DMSO,2840,A-23187 - Ion channel ligands - Calcium ionophore
EI-160,Clofibrate,242.7,1-H10,1,Plate 1,H10,EnzoICCB1,SP0127,O19,ICCB Known Bioactives Library,1,Nuclear receptor ligands:  PPAR alpha agonist,DMSO,2840,Clofibrate - Nuclear receptor ligands - PPAR alpha agonist
CA-410,(R)-(+)-BAY K-8644,356.3,2-H10,2,Plate 2,H10,EnzoICCB1,SP0127,O20,ICCB Known Bioactives Library,14.0332560100927,Ion channel ligands:  Calcium channels,DMSO,2840,Bay K-8644 - Ion channel ligands - Calcium channels
RA-106,Cloprostenol,424.9,1-H11,1,Plate 1,H11,EnzoICCB1,SP0127,O21,ICCB Known Bioactives Library,1,Bioactive lipids:  Prostaglandin FP receptor agonist,DMSO,2840,Cloprostenol Na - Bioactive lipids - Prostaglandin FP receptor agonist
NA-103,Benzamil·HCl,356.2,2-H11,2,Plate 2,H11,EnzoICCB1,SP0127,O22,ICCB Known Bioactives Library,14.0366637657562,Ion channel ligands:  Calcium channels,DMSO,2840,Benzamil - Ion channel ligands - Calcium channels
CM-123,2-methoxyantimycin A3,534.6,3-H02,3,Plate 3,H02,EnzoICCB1,SP0127,P03,ICCB Known Bioactives Library,9.35281162352464,Inhibitors:  Bcl-2/Bcl-XL ligand induces apoptosis,DMSO,2840,2-Methoxyantimycin A3 - Inhibitors - Bcl-2/Bcl-XL ligand induces apoptosis
AC-183,Cimaterol,219.3,4-H02,4,Plate 4,H02,EnzoICCB1,SP0127,P04,ICCB Known Bioactives Library,22.8015955644512,CNS receptor ligands:  adrenoceptor agonist (beta),DMSO,2840,Cimaterol - CNS receptor ligands - adrenoceptor agonist (beta)
CM-122,HA14-1,409.2,3-H03,3,Plate 3,H03,EnzoICCB1,SP0127,P05,ICCB Known Bioactives Library,12.2180382229108,Inhibitors:  Bcl-2 ligand induces apoptosis,DMSO,2840,HA14-1 - Inhibitors - Bcl-2 ligand induces apoptosis
PR-115,CinnGEL ,518.6,4-H03,4,Plate 4,H03,EnzoICCB1,SP0127,P06,ICCB Known Bioactives Library,9.64209507298584,Inhibitors:  PTP1B inhibitor,DMSO,2840,CinnGEL 2Me - Inhibitors - PTP1B inhibitor
CM-115,Decylubiquinone,322.4,3-H04,3,Plate 3,H04,EnzoICCB1,SP0127,P07,ICCB Known Bioactives Library,15.5068042306284,Inhibitors:  inhibits mitochondrial permeability pore opening ,DMSO,2840,Decylubiquinone - Inhibitors - inhibits mitochondrial permeability pore opening 
AC-136,Cirazoline,216.3,4-H04,4,Plate 4,H04,EnzoICCB1,SP0127,P08,ICCB Known Bioactives Library,23.1182977165133,CNS receptor ligands:  adrenoreceptor agonist (alpha),DMSO,2840,Cirazoline - CNS receptor ligands - adrenoreceptor agonist (alpha)
AP-301 ,Betulinic acid,456.7,3-H05,3,Plate 3,H05,EnzoICCB1,SP0127,P09,ICCB Known Bioactives Library,10.9480987860091,Inhibitors:  induces mitochondrial permeability pore opening,DMSO,2840,Betulinic acid - Inhibitors - induces mitochondrial permeability pore opening
AC-152,Clonidine,230.1,4-H05,4,Plate 4,H05,EnzoICCB1,SP0127,P10,ICCB Known Bioactives Library,21.7302493763418,CNS receptor ligands:  adrenoreceptor agonist (alpha),DMSO,2840,Clonidine - CNS receptor ligands - adrenoreceptor agonist (alpha)
EI-240,Deprenyl,187.3,3-H06,3,Plate 3,H06,EnzoICCB1,SP0127,P11,ICCB Known Bioactives Library,26.6978782662184,Inhibitors:  inhibits glyceraldehyde-3-phosphate dehydrogenase,DMSO,2840,Deprenyl - Inhibitors - inhibits glyceraldehyde-3-phosphate dehydrogenase
D-107,Clozapine,326.8,4-H06,4,Plate 4,H06,EnzoICCB1,SP0127,P12,ICCB Known Bioactives Library,15.298800879987,CNS receptor ligands:  Dopamine antagonist,DMSO,2840,Clozapine - CNS receptor ligands - Dopamine antagonist
CN-268,1400W,177.2,3-H07,3,Plate 3,H07,EnzoICCB1,SP0127,P13,ICCB Known Bioactives Library,28.2093494811172,Inhibitors:  iNOS inhibitor,DMSO,2840,1400W - Inhibitors - iNOS inhibitor
EI-135,Curcumin,368.4,4-H07,4,Plate 4,H07,EnzoICCB1,SP0127,P14,ICCB Known Bioactives Library,13.5729446693481,Inhibitors:  NFkappaB inhibitor,DMSO,2840,Curcumin - Inhibitors - NFkappaB inhibitor
SL-220,Fumonisin B1,721.8,3-H08,3,Plate 3,H08,EnzoICCB1,SP0127,P15,ICCB Known Bioactives Library,6.9268387293407,Lipid biosynthesis:  inhibits ceramide synthase,DMSO,2840,Fumonisin B1 - Lipid biosynthesis - inhibits ceramide synthase
GR-310,Cycloheximide,281.3,4-H08,4,Plate 4,H08,EnzoICCB1,SP0127,P16,ICCB Known Bioactives Library,17.7716232671779,Inhibitors:  protein synthesis inhibitor ,DMSO,2840,Cycloheximide - Inhibitors - protein synthesis inhibitor 
AP-304,Triptolide,360.4,3-H09,3,Plate 3,H09,EnzoICCB1,SP0127,P17,ICCB Known Bioactives Library,13.8734354233201,Inhibitors:  inhibits NFkappaB transcriptional activation,DMSO,2840,Triptolide - Inhibitors - inhibits NFkappaB transcriptional activation
A-195,Cyclosporin A,1202.6,4-H09,4,Plate 4,H09,EnzoICCB1,SP0127,P18,ICCB Known Bioactives Library,4.15761968622943,Inhibitors:  calcineurin inhibitor,DMSO,2840,Cyclosporin A - Inhibitors - calcineurin inhibitor
GR-336,Tanshinone IIA,294.3,3-H10,3,Plate 3,H10,EnzoICCB1,SP0127,P19,ICCB Known Bioactives Library,16.9869037766643,Inhibitors:  AP-1 inhibitor,DMSO,2840,Tanshinone IIA - Inhibitors - AP-1 inhibitor
PR-100,Cypermethrin,416.3,4-H10,4,Plate 4,H10,EnzoICCB1,SP0127,P20,ICCB Known Bioactives Library,12.0106558538736,Inhibitors:  calcineurin inhibitor,DMSO,2840,Cypermethrin - Inhibitors - calcineurin inhibitor
CA-421,Nigericin,725.0,3-H11,3,Plate 3,H11,EnzoICCB1,SP0127,P21,ICCB Known Bioactives Library,6.89691987696447,Inhibitors:  induces intracellular acidification,DMSO,2840,Nigericin - Inhibitors - induces intracellular acidification
T-108,Cytochalasin B,479.6,4-H11,4,Plate 4,H11,EnzoICCB1,SP0127,P22,ICCB Known Bioactives Library,10.4251849115048,Inhibitors:  F actin capper,DMSO,2840,Cytochalasin B - Inhibitors - F actin capper